0001209191-23-013695.txt : 20230228 0001209191-23-013695.hdr.sgml : 20230228 20230228164444 ACCESSION NUMBER: 0001209191-23-013695 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230224 FILED AS OF DATE: 20230228 DATE AS OF CHANGE: 20230228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ambrose Kristen CENTRAL INDEX KEY: 0001856587 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 23686411 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-24 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001856587 Ambrose Kristen C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP & Chief Accounting Officer Common Stock 2023-02-24 4 F 0 502 289.12 D 8510 D Common Stock 2023-02-27 4 S 0 982 287.25 D 7528 D Common Stock 2023-02-27 4 S 0 183 288.68 D 7345 D Common Stock 2023-02-27 4 S 0 42 289.63 D 7303 D Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1. Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $287.25 (range $286.79 to $287.71). Open market sales reported on this line occurred at a weighted average price of $288.68 (range $288.24 to $289.17). /s/ Joy Liu, Attorney-in-Fact 2023-02-28